You are here

Article Text

Article menu

Download PDFPDF

Correspondence
Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine
Free
  1. Martin Michaud,
  2. Florian Catros,
  3. Sophie Ancellin,
  4. Francis Gaches
  1. Department of Internal Medicine, Hopital Joseph Ducuing, Toulouse, France
  1. Correspondence to Dr Martin Michaud, Department of Internal Medicine, Joseph Ducuing Hospital, 31076 Toulouse, France; mmichaud{at}hjd.asso.fr

https://doi.org/10.1136/annrheumdis-2019-215799

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the last 2019 update of the European League Against Rheumatism recommendations for the management of systemic lupus erythematosus (SLE).1 We agree with the comment by Gabriel Figueroa-Parra et al concerning the lack of mention of chloroquine as major treatment in SLE.2

    Concerning survival, the LUMINA study group also showed that use of hydroxychloroquine (HCQ) was associated with a greater survival rate in 608 patients with SLE.3 Ruiz-Irastorza et al confirmed …

    View Full Text

    Linked Articles